when was semaglutide fda approved Approval vs Compounded Alternatives FDA Approves Oral Semaglutide for

Have a BMI of 27 or higher with weight-related health issues such as high blood pressure or prediabetes

Other Factors That Strengthen Candidacy Several other factors can influence GLP-1 therapy eligibility beyond BMI and weight-related medical conditions

For women, GLP-1 medications can be a powerful part of a weight loss and wellness plan

Patients Seeking Preventative Health Measures Even individuals who are not significantly overweight can benefit from micro-dosing GLP-1 medications as a preventative measure

This personalized data empowers you to work with your fertility provider and PlexusDx team to design a preconception plan aligned with your genetic biology, not just population averages

Bottom line: MeAgain treats shot day as the start of the journey, not the whole job